Parra, G. A., H. H. Lindarte, and A. F. Rubio. 2020. “Over Optimum Response to PCSK-9 Inhibitors: ¿is It Mandatory to Supply Them Every 2 weeks?, about a Case”. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo 7 (1):43-44. https://doi.org/10.53853/encr.7.1.568.